HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Akira Sato Selected Research

Chronic Hepatitis C

5/2016Delayed Viral Clearance after 6-Week Treatment with Peginterferon Plus Ribavirin in a Patient with Chronic Hepatitis C Virus Genotype 1b.
4/2016Sustained virological response after a 17-day treatment with daclatasvir plus asunaprevir in a cirrhotic patient with hepatitis C virus genotype 1b and null response for peginterferon ribavirin therapy.
1/2016Hemoglobin Decrease with Iron Deficiency Induced by Daclatasvir plus Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b.
8/2014Successful natural interferon-β plus ribavirin therapy in a chronic hepatitis C patient after discontinuation of interferon-α treatment due to arrhythmia and interstitial pneumonia.
1/2013Clinical characteristics of patients who developed hepatocellular carcinoma after hepatitis C virus eradication with interferon therapy: current status in Japan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Akira Sato Research Topics

Disease

45Neoplasms (Cancer)
03/2024 - 01/2006
30Atrial Fibrillation
10/2021 - 04/2008
23Coronary Artery Disease (Coronary Atherosclerosis)
12/2023 - 07/2007
18Atherosclerosis
01/2022 - 06/2005
17Necrosis
07/2023 - 01/2006
16Heart Failure
11/2023 - 01/2006
14Inflammation (Inflammations)
10/2022 - 09/2005
13Atherosclerotic Plaque (Atheroma)
01/2022 - 06/2005
12Myocardial Infarction
01/2024 - 06/2006
12Cardiovascular Diseases (Cardiovascular Disease)
12/2023 - 06/2006
11Infections
01/2019 - 10/2007
10Tachycardia (Tachyarrhythmias)
01/2021 - 06/2009
9Malaria
08/2023 - 09/2011
9Thrombosis (Thrombus)
11/2020 - 03/2014
8Colorectal Neoplasms (Colorectal Cancer)
03/2024 - 12/2019
8Hemorrhage
06/2020 - 01/2006
6Ventricular Tachycardia
03/2024 - 06/2006
5ST Elevation Myocardial Infarction
01/2024 - 06/2012
5Hypertension (High Blood Pressure)
10/2021 - 12/2010
5Neoplasm Metastasis (Metastasis)
10/2021 - 02/2012
5Kidney Diseases (Kidney Disease)
01/2020 - 08/2013
5Lung Neoplasms (Lung Cancer)
01/2020 - 01/2017
5Aortic Dissection
06/2018 - 10/2013
5Fibrosis (Cirrhosis)
11/2017 - 02/2012
5Acute Coronary Syndrome
01/2017 - 10/2012
5Acute Kidney Injury (Acute Renal Failure)
07/2016 - 01/2014
5Chronic Hepatitis C
05/2016 - 01/2013
4Pathologic Constriction (Stenosis)
01/2024 - 01/2010
4Abdominal Aortic Aneurysm
10/2022 - 05/2006
4Edema (Dropsy)
10/2022 - 03/2005
4Hypotension (Low Blood Pressure)
10/2022 - 10/2012
4Anaphylaxis (Anaphylactic Shock)
10/2022 - 01/2017
4Virus Diseases (Viral Diseases)
01/2021 - 11/2010
4Carcinoma (Carcinomatosis)
08/2020 - 06/2008
4Heart Diseases (Heart Disease)
01/2019 - 03/2012
4Squamous Cell Carcinoma (Epidermoid Carcinoma)
11/2017 - 06/2008
4Stroke (Strokes)
01/2017 - 05/2013
4Type 2 Diabetes Mellitus (MODY)
01/2015 - 11/2003
4Unstable Angina
01/2014 - 02/2009
3Atrioventricular Block
03/2024 - 10/2012
3Amyloidosis
03/2024 - 11/2023
3Body Weight (Weight, Body)
03/2024 - 01/2006
3Glioblastoma (Glioblastoma Multiforme)
01/2024 - 01/2019
3Infarction (Infarctions)
01/2024 - 08/2013
3Aortic Valve Stenosis (Aortic Stenosis)
09/2023 - 01/2021
3Hypothermia
10/2022 - 09/2017
3Ascites
02/2022 - 10/2007
3Coronary Stenosis (Coronary Artery Stenosis)
10/2021 - 01/2013
3Spasm (Spasms)
08/2021 - 09/2008

Drug/Important Bio-Agent (IBA)

21Proteins (Proteins, Gene)FDA Link
07/2023 - 08/2002
19Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2022 - 02/2009
16oxidized low density lipoproteinIBA
01/2022 - 09/2012
14Floxuridine (FUdR)FDA LinkGeneric
07/2023 - 01/2006
11Peptides (Polypeptides)IBA
10/2022 - 08/2013
8TenascinIBA
01/2019 - 06/2006
85-fluoro-2'-deoxyuridineIBA
01/2017 - 01/2008
7Antimalarials (Antimalarial Agents)IBA
08/2023 - 12/2011
7LipidsIBA
10/2022 - 05/2012
7InterferonsIBA
02/2022 - 01/2013
6Fluorouracil (Carac)FDA LinkGeneric
03/2024 - 01/2015
6LDL Lipoproteins (beta Lipoproteins)IBA
01/2023 - 01/2016
6tyrosyl-lysineIBA
10/2022 - 08/2013
6PapaverineIBA
01/2021 - 04/2018
6Contrast MediaIBA
01/2020 - 08/2013
5omega-Chloroacetophenone (Mace)IBA
12/2023 - 06/2006
5Platelet Activating FactorIBA
10/2022 - 04/2013
5aspartylglycineIBA
10/2022 - 08/2013
5Receptor for Advanced Glycation End ProductsIBA
12/2020 - 07/2007
5C-Reactive ProteinIBA
11/2020 - 06/2005
5MicroRNAs (MicroRNA)IBA
11/2020 - 06/2010
5Biomarkers (Surrogate Marker)IBA
03/2018 - 05/2011
5DNA (Deoxyribonucleic Acid)IBA
11/2017 - 10/2002
5Ribavirin (Virazole)FDA LinkGeneric
04/2017 - 01/2013
5pitavastatin (itavastatin)FDA Link
01/2015 - 06/2005
4Glucose (Dextrose)FDA LinkGeneric
03/2024 - 07/2012
4Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2024 - 01/2017
4nonadecaneIBA
08/2023 - 09/2011
4SteroidsIBA
03/2022 - 12/2003
4Brain Natriuretic Peptide (Natrecor)FDA Link
11/2021 - 12/2009
4CytokinesIBA
01/2021 - 01/2007
4Fluorescent Dyes (Fluorescent Probes)IBA
10/2020 - 01/2016
4CalciumIBA
01/2019 - 02/2012
4Pravastatin (Pravachol)FDA LinkGeneric
01/2015 - 06/2013
3estrone sulfotransferaseIBA
01/2022 - 10/2020
3RNA (Ribonucleic Acid)IBA
01/2021 - 04/2016
3Lysophosphatidylcholines (Lysophosphatidylcholine)IBA
01/2021 - 09/2012
3Estrogens (Estrogen)FDA Link
01/2021 - 10/2011

Therapy/Procedure

51Therapeutics
12/2023 - 03/2005
23Catheter Ablation
03/2024 - 04/2008
23Percutaneous Coronary Intervention
01/2024 - 02/2009
12Drug Therapy (Chemotherapy)
01/2024 - 01/2009
12Stents
11/2020 - 02/2013
6Catheters
08/2023 - 01/2012
5Radiofrequency Ablation
08/2023 - 12/2007
4Transcatheter Aortic Valve Replacement
03/2024 - 01/2021
4Aftercare (After-Treatment)
02/2022 - 05/2009
4Chemoradiotherapy
01/2019 - 06/2008
3Secondary Prevention
01/2024 - 02/2009
3Radiotherapy
01/2024 - 06/2008
3Patient Readmission
01/2023 - 02/2008